Peptides

Selank

A synthetic peptide developed in Russia as an anti-anxiety agent — without the sedation, dependence, or cognitive blunting of traditional anxiolytics. Here's what the evidence says and what you should know.

Emerging evidence Nasal spray or subcutaneous Anxiety & cognition 3 min read

Selank is a synthetic heptapeptide derived from tuftsin (an immune-modulating peptide) developed at the Russian Academy of Sciences. It’s been approved in Russia as an anxiolytic and nootropic nasal spray. It modulates GABA, serotonin, and dopamine systems without causing sedation or dependence.

Route
Nasal spray (primary) or subcutaneous
Common dose
250–500 mcg/day (nasal)
Research stage
Approved in Russia; limited Western trials
Legal status (India)
Unregulated research chemical

Often used by: People with generalised anxiety who want to avoid benzodiazepine-type drugs, those interested in mild cognitive enhancement, and individuals exploring peptide-based nootropics.

Dive deeper into the research

Common side effects

  • Mild nasal irritation with spray use
  • Occasional fatigue, usually in the first few days
  • Very rare: mild headache during initial use
See all side effects

What does Selank do?

Selank works on several neurotransmitter systems simultaneously. It influences GABA signalling (the same system benzodiazepines target, but without the sedation or dependence risk), modulates serotonin metabolism, and affects BDNF (brain-derived neurotrophic factor) expression.

The result is anxiolytic and mild nootropic — reduced anxiety with maintained or improved cognitive clarity. Russian clinical studies report reduced anxiety scores comparable to low-dose benzodiazepines, but without the cognitive blunting, sedation, or withdrawal issues.

It also has immunomodulatory properties inherited from its parent molecule tuftsin, potentially stabilising immune responses in people with chronic stress-related immune dysregulation.

Who uses it?

What to know before trying

Important

Selank is approved in Russia but not in India, the US, or Europe. Russian clinical data exists but is mostly published in Russian-language journals with limited access to Western peer review. Approach with appropriate caution.

Nasal spray is primary: Most users and Russian clinical protocols use the nasal spray form. Subcutaneous injection is an alternative but less studied for this specific peptide.

Effects are subtle: Don’t expect a dramatic anxiolytic "hit" like a benzodiazepine. Selank’s effects are gradual and subtle — a calmer baseline rather than acute sedation. Most people notice the difference after 3–7 days of consistent use.

Not a replacement for medical treatment: If you have diagnosed anxiety disorder, selank is not a substitute for professional treatment. It may complement an existing plan under physician guidance.

Want to track if your peptide protocol is working?

eterni connects your labs, supplements, and retests — so you can see real data, not just guesswork.

Get early access

Frequently Asked Questions

Does selank work for anxiety?

Russian clinical studies show anxiety score reductions comparable to low-dose benzodiazepines. The effects are subtler — a calmer baseline rather than acute sedation. No dependence or withdrawal has been reported. The limitation: most studies are in Russian-language journals with limited Western peer review.

How does selank compare to benzodiazepines?

Selank modulates GABA without the sedation, cognitive impairment, or dependence that benzodiazepines cause. The trade-off is that the anxiolytic effect is milder and more gradual. For severe acute anxiety, benzodiazepines are more potent. For chronic low-grade anxiety with cognitive demands, selank may offer a better profile.

How do I use selank nasal spray?

The standard Russian protocol is 250–500 mcg intranasally per day, typically split into 2–3 doses. Effects begin within 3–7 days of consistent use. Cycles of 2–4 weeks are commonly used. Store reconstituted solution refrigerated.

Is selank safe?

Russian clinical data shows a favourable safety profile with minimal reported side effects. No dependence, tolerance, or withdrawal has been documented. Mild nasal irritation is the most common complaint. Long-term safety data in non-Russian populations is limited.

Research & Science

How it works in your body

Selank modulates enkephalin metabolism (endogenous opioid peptides involved in stress response), influences GABA-A receptor signalling, and affects serotonin and dopamine turnover in the brain. It also increases BDNF expression, which is associated with neuroplasticity and resilience to stress. Its parent molecule tuftsin provides immunomodulatory effects through natural killer cell and phagocyte activation.

What the studies show

What to monitor

Selank doesn’t require specific lab monitoring. Track anxiety symptoms subjectively using a validated scale (GAD-7) before and during use. Note any changes in sleep quality, cognitive performance, and stress resilience.

Side effects & safety

Selank has a well-tolerated profile based on available clinical data:

Who should be cautious: People on psychiatric medications (potential interactions with serotonin or GABA-modulating drugs), pregnant or breastfeeding women, and those with autoimmune conditions (due to immune-modulating effects).

Know what's working. Know what's not.

eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.

Join the waitlist

Related